The Venture Codex Logo

The Venture Codex

Takeda

1-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo, 103-8668, Japan

Overview

Pharmaceutical company specializing in drugs and therapeutics.

Founded

1781

Deals ยท 12mo

3

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series A

Geographic focus

United States

Sector focus

Biotechnology
Health Care
Manufacturing
Medical
...

Investment portfolio

22rounds
NAMEDATESIZE
Accipiter Biosciences
Jul 2026Led
$11 MSeed
Beacon Biosignals
Nov 2025Participated
$86 MSeries B
Accipiter Biosciences
Nov 2025Led
$13 MSeed
LOGZ Group
Jun 2024Participated
$0.63 MOther Equity
Ascentage Pharma
Jun 2024Led
$75 MOther Equity
Crescendo Biologics
Jul 2023Participated
$32 MOther Equity
Ambys Medicines
Dec 2021Participated
$47 MSeries A
Cardurion Pharmaceuticals
Oct 2021Participated
$300 MOther Equity
Carmine Therapeutics
Jun 2020Led
$5 MOther Equity
ENTEROME
Jun 2020Participated
$52 MSeries E
Amwell
May 2020Participated
$194 MSeries C
Ambys Medicines
Aug 2018Led
$60 MSeries A
Accipiter Biosciences
Jul 2026Led
$11 MSeed
Beacon Biosignals
Nov 2025Participated
$86 MSeries B
Accipiter Biosciences
Nov 2025Led
$13 MSeed
LOGZ Group
Jun 2024Participated
$0.63 MOther Equity
Ascentage Pharma
Jun 2024Led
$75 MOther Equity
Crescendo Biologics
Jul 2023Participated
$32 MOther Equity
Ambys Medicines
Dec 2021Participated
$47 MSeries A
Cardurion Pharmaceuticals
Oct 2021Participated
$300 MOther Equity
Carmine Therapeutics
Jun 2020Led
$5 MOther Equity
ENTEROME
Jun 2020Participated
$52 MSeries E
Amwell
May 2020Participated
$194 MSeries C
Ambys Medicines
Aug 2018Led
$60 MSeries A
22
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Takeda: 22 funding rounds are recorded in the selected participation categories.All available history.
Takeda: 22 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed20
Series A22
Series B11
Series C+14
Other Equity63

Monthly Deal Activity

Takeda: 22 deals are recorded across 146 months.All available history.
Takeda: 22 deals are recorded across 146 months. All available history
MonthDeals
Sep '141
Oct '140
Nov '140
Dec '140
Jan '150
Feb '150
Mar '150
Apr '150
May '150
Jun '150
Jul '150
Aug '150
Sep '150
Oct '150
Nov '150
Dec '152
Jan '161
Feb '160
Mar '160
Apr '160
May '160
Jun '161
Jul '160
Aug '160
Sep '160
Oct '160
Nov '160
Dec '161
Jan '172
Feb '170
Mar '170
Apr '171
May '170
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '180
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '181
Aug '181
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '201
Jun '202
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '211
Nov '210
Dec '211
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '231
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '242
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '252
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '261
Aug '260
Sep '260
Oct '260

Sector Breakdown

Takeda: Health & Life Sciences is the largest displayed sector by deal count (21 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Takeda: Health & Life Sciences is the largest displayed sector by deal count (21 deals). All available history
SectorDeals
Health & Life Sciences21
AI & Machine Learning2
Hardware & Robotics1
Education & Workforce1
Enterprise Software1
Professional Services1
Space & Frontier Tech1

Deal Size Distribution

Takeda: 22 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Takeda: 22 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M1
$5M-$10M3
$10M-$25M7
$25M-$50M5
$50M-$100M4
$100M-$250M1
$250M-$500M1
$500M-$1B0
$1B+0

Deals By Geography

Takeda: United States has the largest recorded deal count among the displayed regions (18 deals).All available history.

Top 4 of 4 regions; European countries are grouped as Europe.

Takeda: United States has the largest recorded deal count among the displayed regions (18 deals). All available history
RegionDeals
United States18
Europe2
Japan1
China1
Takeda: 20 co-investors are shown, with Alexandria Venture Investments sharing 4 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Takeda: 20 co-investors are shown, with Alexandria Venture Investments sharing 4 recorded deals. All available history
Co-investorShared deals
Alexandria Venture Investments4
Argonautic Ventures2
Cercano Management2
Columbus Venture Partners2
Flying Fish Partners2
Pack Ventures2
Third Rock Ventures2
WRF Capital2
Alethea Capital1
Allianz X1
Andera Partners1
Arrowpoint Partners1
Bain Capital Life Sciences1
Bain Capital Private Equity1
Brace Pharma Capital1
Casdin Capital1
Catalio Capital Management1
Celgene1
Cormorant Asset Management1
Dolby Family Ventures1

Investment Strategy

Takeda: Led accounts for 55% and participating for 45% of round participation.All available history.
Takeda: Led accounts for 55% and participating for 45% of round participation. All available history
CategoryDeals (count)Share (%)
Led1255%
Participating1045%
Takeda: Single-lead accounts for 58% and co-led for 42% of lead dynamics.All available history.
Takeda: Single-lead accounts for 58% and co-led for 42% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead758%
Co-led542%

Team

Bin Li

Director of Computational Biology, Takeda Data Science Institute

Christopher Barr

Takeda Community Engagement

Henry Werner

Communication Director Nordics & Baltics

Masaru Otsuka

Head of Digital Acceleration

Patrycja Lakomiak

Head Of Supply Chain Coordination

Rekha Paleyanda

Director

Schuyler Fairfield

SVP, Global Head of Supply Chain

Yasuchika Hasegawa

Chairman of the Board & CEO